BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5162177)

  • 1. The pathology of Parkinsonism. Part I. Some new observations and correlations.
    Forno LS; Alvord EC
    Contemp Neurol Ser; 1971; 8():119-30. PubMed ID: 5162177
    [No Abstract]   [Full Text] [Related]  

  • 2. The pathology of Parkinsonism. II. An interpretation with special reference to other changes in the aging brain.
    Alvord EC
    Contemp Neurol Ser; 1971; 8():131-61. PubMed ID: 5162178
    [No Abstract]   [Full Text] [Related]  

  • 3. Parkinsonism and neurofibrillary tangle pathology in pigmented nuclei.
    Rajput AH; Uitti RJ; Sudhakar S; Rozdilsky B
    Ann Neurol; 1989 Jun; 25(6):602-6. PubMed ID: 2662896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of the brain stem lesions in postencephalitic Parkinsonism.
    Torvik A; Meen D
    Acta Neurol Scand; 1966; 42(4):415-25. PubMed ID: 5919815
    [No Abstract]   [Full Text] [Related]  

  • 5. A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics.
    Bogerts B; Häntsch J; Herzer M
    Biol Psychiatry; 1983 Sep; 18(9):951-69. PubMed ID: 6640008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural observations in Parkinsonism.
    Roy S; Wolman L
    J Pathol; 1969 Sep; 99(1):39-44. PubMed ID: 5359222
    [No Abstract]   [Full Text] [Related]  

  • 7. The pathology of Parkinsonism: a comparison of degenerations in cerebral cortex and brainstem.
    Alvord EC; Forno LS; Kusske JA; Kauffman RJ; Rhodes JS; Goetowski CR
    Adv Neurol; 1974; 5():175-93. PubMed ID: 4374061
    [No Abstract]   [Full Text] [Related]  

  • 8. [Quantitative studies of neurons of the substantia nigra and basal ganglia in parkinsonism].
    Togi H; Ogawa M; Yamanouchi H; Tomonaga M; Kameyama M
    Rinsho Shinkeigaku; 1976 Apr; 16(4):311-8. PubMed ID: 986268
    [No Abstract]   [Full Text] [Related]  

  • 9. [A 78-year-old man with young onset parkinsonism and sudden death].
    Miyasaka H; Mori H; Saikawa T; Shirai T; Kondo T; Imai H; Mizuno Y
    No To Shinkei; 1996 May; 48(5):487-95. PubMed ID: 8672309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Distribution of Alzheimer's neurofibrillar changes (NFA) in postencephalitic parkinsonism].
    Ishii T
    Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):909-19. PubMed ID: 5753788
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunocytochemical comparison of neurofibrillary tangles in senile dementia of Alzheimer type, progressive supranuclear palsy, and postencephalitic parkinsonism.
    Yen SH; Horoupian DS; Terry RD
    Ann Neurol; 1983 Feb; 13(2):172-5. PubMed ID: 6187274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postencephalitic parkinsonism responsive to a dopamine agonist: A case report.
    Kim R; Shin CW; Kim HJ; Jeon BS
    Parkinsonism Relat Disord; 2015 Jun; 21(6):667-8. PubMed ID: 25899543
    [No Abstract]   [Full Text] [Related]  

  • 13. Depigmentation in the nerve cells of the substantia nigra and locus ceruleus in Parkinsonism.
    Forno LS; Alvord EC
    Adv Neurol; 1974; 5():195-202. PubMed ID: 4374062
    [No Abstract]   [Full Text] [Related]  

  • 14. "Minimal change" multiple system atrophy.
    Wenning GK; Quinn N; Magalhăes M; Mathias C; Daniel SE
    Mov Disord; 1994 Mar; 9(2):161-6. PubMed ID: 8196676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinico-pathomorphologic correlations in parkinsonism].
    Starikov AS; Obraztsova RG; Kleĭn AV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(12):28-32. PubMed ID: 6762023
    [No Abstract]   [Full Text] [Related]  

  • 16. [Certain features of the clinical picture and pathomorphology of Parkinson disease of different etiology].
    Martynov IuS; Zenkevich GS; Tochilovskiĭ AS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(7):1033-9. PubMed ID: 7415721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postencephalitic parkinsonism and selective involvement of substantia nigra.
    He S; Yuan LP; Zhang JW; Han X
    Neurol Sci; 2015 Apr; 36(4):653-5. PubMed ID: 25577509
    [No Abstract]   [Full Text] [Related]  

  • 18. Parkinsonism--neuropathology.
    Lewis PD
    Br Med J; 1971 Sep; 3(5776):690-2. PubMed ID: 4936440
    [No Abstract]   [Full Text] [Related]  

  • 19. Striatonigral degeneration, Alzheimer's disease, and inflammatory changes.
    Trotter JL
    Neurology; 1973 Nov; 23(11):1211-6. PubMed ID: 4795740
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical pictures and pathological changes in cases with the lesion of the substantia nigra].
    Tatetsu S
    Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):963-70. PubMed ID: 5753742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.